Answer
Sep 26, 2024 - 01:57 PM
Ubrelvy (ubrogepant) should not be taken with strong CYP3A4 inhibitors such as ketoconazole, clarithromycin, and itraconazole, as these can increase the levels of Ubrelvy in the blood and potentially lead to adverse effects. Additionally, it is advised to avoid taking Ubrelvy with strong CYP3A4 inducers like rifampin, as these can decrease its effectiveness. Always consult with a healthcare provider for personalized advice.